#NSCLC

Lead report

Summit Therapeutics Announces FDA PDUFA Date for Ivonescimab and HARMONi-3 Data Timeline

Summit Therapeutics sets FDA PDUFA target date for ivonescimab on November 14 and plans HARMONi-3 PFS data readout in H2 2026. Analysis of regulatory decisions and clinical progress impacts on stock and industry landscape.